Scientific Presentations
ATT-01 · AML
Intratumoral ATTImmune Scaffold Delivering GM-CSF & CpG for Treatment of Acute Myeloid Leukemia
Preclinical data demonstrating the efficacy of ATT-01, Attivare's lead AML program, using the ATTImmune biomaterial scaffold for localized co-delivery of GM-CSF and CpG directly to the tumor microenvironment.
ATT-02 · Solid Tumors
Intratumoral ATTImmune Scaffold Delivering IL-12 Drives Abscopal Effects & Complete Response in Solid Tumors
Preclinical data for ATT-02 demonstrating robust tumor microenvironment modulation, abscopal (systemic) immune effects, and complete responses in solid tumor models using localized IL-12 delivery via ATTImmune.
ATT-01 Poster — AML
ATT-02 Poster — Solid Tumors